Ron Frieson Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Ron Frieson is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 93,800 shares of AKBA, which is worth approximately $218,554. The most recent transaction as insider was on Jan 17, 2025, when has been sold 20,100 shares (Common Stock) at a price of $0.45 per share, resulting in proceeds of $9,045. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.8K
27.27% 3M change
114.65% 12M change
Total Value Held $218,554

RON FRIESON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2025
BUY
Exercise of conversion of derivative security
$9,045 $0.45 p/Share
20,100 Added 17.65%
93,800 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 28.93%
73,700 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 40.71%
43,700 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
13,700 Added 50.0%
13,700 Common Stock
RF

Ron Frieson

Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA